Aptorum Group Limited (APM)

NASDAQ: APM · Real-Time Price · USD

0.736

-0.009 (-1.22%)

At close: Nov 20, 2024, 4:00 PM

0.751

+0.015 (2.09%)

After-hours: Nov 20, 2024, 7:58 PM EST

Aptorum Group Employees

Aptorum Group had 3 employees as of December 31, 2023. The number of employees decreased by 16 or -84.21% compared to the previous year.

Employees

3

Change (1Y)

-16

Growth (1Y)

-84.21%

Revenue / Employee

$143,793

Profits / Employee

-$941,549

Market Cap

4.03M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	3	-16	-84.21%
Dec 31, 2022	19	-7	-26.92%
Dec 31, 2021	26	0	-
Dec 31, 2020	26	-11	-29.73%
Dec 31, 2019	37	-4	-9.76%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Biofrontera	85
Genetic Technologies	55
Predictive Oncology	35
Hepion Pharmaceuticals	22
Windtree Therapeutics	20
Sonoma Pharmaceuticals	10
Pasithea Therapeutics	8
Artelo Biosciences	6

Employee Rankings

APM News

7 months ago - Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update - Business Wire
9 months ago - Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business - Business Wire
11 months ago - Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023 - Business Wire
11 months ago - Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders - Business Wire
1 year ago - Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 - Business Wire
1 year ago - Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets - Business Wire
1 year ago - Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma - Business Wire
1 year ago - Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris - Business Wire